MarketCap
Facebook
X
TelegramAnnual report 2021
added 12-23-2023
Neovasc Total Non Current Liabilities 2011-2026 | NVCN
Annual Total Non Current Liabilities Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 8.24 M | 9.83 M | 13.4 M | 32.6 M | - | - | 136 K | 188 K | 242 K | 275 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 32.6 M | 136 K | 8.11 M |
Quarterly Total Non Current Liabilities Neovasc
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 9.02 M | - | - | - | 8.24 M | - | - | - | 9.83 M | - | - | - | 15.6 M | - | - | - | 32.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 32.6 M | 8.24 M | 15.1 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
89.9 M | $ 12.87 | -1.0 % | $ 1.93 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 38.31 | -0.51 % | $ 5.71 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 8.37 | 2.2 % | $ 601 M |  Israel |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 9.44 | -2.38 % | $ 1.28 B | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 42.35 | -1.5 % | $ 1.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 4.27 | 0.47 % | $ 159 M |  France |
 |
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | USA |
 |
Electromed
ELMD
|
8.87 K | $ 24.29 | - | $ 205 M | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
1.61 M | $ 29.02 | -0.68 % | $ 1.34 B | USA |
 |
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.23 | -2.12 % | $ 112 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
161 M | - | - | $ 10.2 M | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
FONAR Corporation
FONR
|
36.4 M | $ 18.49 | -0.24 % | $ 121 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
196 M | $ 0.52 | -0.9 % | $ 53.4 M | USA |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.8 | 1.27 % | $ 43.5 M | USA |
 |
Align Technology
ALGN
|
184 M | $ 178.91 | -1.78 % | $ 13.4 B | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
25.7 B | $ 111.71 | -1.19 % | $ 194 B | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
InMode Ltd.
INMD
|
12.5 M | $ 13.57 | 0.04 % | $ 877 M | Israel |
 |
Boston Scientific Corporation
BSX
|
11.8 B | $ 71.83 | -0.53 % | $ 106 B | USA |
 |
IRadimed Corporation
IRMD
|
4.76 M | $ 103.22 | -1.8 % | $ 1.31 B | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.41 | - | $ 22.7 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 17.71 | -4.15 % | $ 415 M | USA |
 |
Helius Medical Technologies
HSDT
|
252 K | $ 2.24 | -3.03 % | $ 1.36 M | USA |
 |
Pulmonx Corporation
LUNG
|
25 M | $ 1.64 | 13.89 % | $ 64.1 M | USA |
 |
Medigus Ltd.
MDGS
|
607 K | - | 10.28 % | $ 55.5 M | Israel |
 |
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 84.22 | -1.16 % | $ 49.3 B | USA |
 |
Medtronic PLC
MDT
|
29.6 B | $ 94.35 | -1.31 % | $ 121 B | USA |